Sarkis Clinical Trials

Summary

Sarkis Clinical Trials is a medical facility located in Gainesville, Florida. This center is recognized for care of Attention-Deficit/Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Depression, Autism Spectrum Disorder and other specialties. Sarkis Clinical Trials is involved with conducting 151 clinical trials across 143 conditions. There are 1 research doctors associated with this hospital, such as John Fort, MD.

Top PIs

Clinical Trials running at Sarkis Clinical Trials

Migraine

Depression

Relapse

Motor and sensory neuropathy

Multiple Sclerosis

Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

Hyperacusis

Photophobia

Nausea and Vomiting

Rimegepant

for Pediatric Migraine

This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.

Recruiting

2 awards

Phase 3

8 criteria

Oral Atogepant Tablets

for Migraine

This trial is testing a medication called atogepant to treat migraines in children and teenagers aged 6 to 17. The study aims to see if atogepant is safe and effective for this age group. Atogepant helps by blocking a protein that triggers migraines, potentially reducing their occurrence and intensity. Atogepant is a newly approved oral medication for the prevention of episodic migraine in adults.

Recruiting

1 award

Phase 3

4 criteria

Ubrogepant

for Pediatric Migraine

This trial will test if ubrogepant is safe and effective for young people with migraines. Ubrogepant is a medication taken by mouth to treat migraine headaches. It works by blocking a protein in the brain that causes migraine pain. The study focuses on children and adolescents who suffer from migraines.

Recruiting

1 award

Phase 3

4 criteria